Ticker
TARSCompany Name
TARSUS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 474.43M | $ 6.41M | $ 90.25M | 5.19 |
3/31/2025 | $ 480.77M | $ 5.24M | $ 86.31M | 5.51 |
12/31/2024 | $ 356.7M | $ 5.15M | $ 80.61M | 4.36 |
9/30/2024 | $ 357.12M | $ 5.38M | $ 65.87M | 5.34 |
6/30/2024 | $ 362.59M | $ 4.73M | $ 51.57M | 6.94 |
3/31/2024 | $ 340.72M | $ 4.04M | $ 42.53M | 7.92 |
12/31/2023 | $ 256.13M | $ 3.11M | $ 36.94M | 6.85 |
9/30/2023 | $ 259.28M | $ 15K | $ 23.25M | 11.15 |
6/30/2023 | $ 183.48M | $ 0 | $ 14.77M | 12.43 |
3/31/2023 | $ 208.65M | $ 0 | $ 13.26M | 15.74 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for TARSUS PHARMACEUTICALS INC is calculated as follows: (AssetsC [ $ 89.07M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 6.14M ]
(=) Quick Ratio [ 14.5 ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |